Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23746666 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer
Condition: Recurrent and/or Metastatic Head and Neck Cancer
Interventions: Drug: ARM 2;   Drug: ARM 1

Indicates status has not been verified in more than two years